🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Cardiac substructure delineation in radiation therapy – A state-of-the-art review. pubmed.ncbi.nlm.nih.gov/38757728/

Here's our new #publication Clinical trials in older patients with cancer – typical challenges, possible solutions, and a paradigm of study design… medicaljournalssweden.se/actaoncologica…

The Full Program for #SABCS24 is out SABCS Look who’s around… #radonc #medonc #surgonc #BreastCancer #OncoAlert OncoAlert Università di Firenze Azienda Ospedaliero-Universitaria Careggi sabcs.org/FullProgram

🧬Cancer types and genes associated with germline mutations 👇 ASCO OncoAlert JCO Precision Oncology #cancer #oncology #genetics #MedX

🔥off the press👉 We have defined a new cardiac anatomical region at risk for radiotherapy The cardiac avoidance area is described and an atlas provided to facilitate implementation Kathryn Banfill 💙 The Christie NHS Manchester Cancer Research Centre jtocrr.org/article/S2666-…

💕 Important findings on risk-reducing surgeries & survival in young #BRCA carriers with #BreastCancer presented by the Matteo Lambertini, MD PhD at #SABCS24. Crucial evidence shaping future care! 👏👏 OncoAlert SABCS

Presented at #SABCS24: Interim results from the EUROPA trial: Single-modality #endocrinetherapy vs #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #breastcancer thelancet.com/journals/lanon…

#SABCS24 Icro Meattini presents interim analysis of the Europa trial. Older women with stage I lo KI67. HR+ BC Rand to RT vs ET. 24 mo FU. No recurrences yet. RT less toxic, 12% stopped ET. 850 enrolled, need more data and longer FU. Pub today in lancet oncol. OncoAlert

EUROPA trial is out in Lancet Oncology Excellent work Icro Meattini thelancet.com/journals/lanon…

One is excessive, but which one? #SABCS24 de-escalation summary👇

📚For everyone interested in combination strategy: don’t miss this multidisciplinary course! I’ll be waiting for you🫵🏻

Be careful while mentioning dietary supplements for your curative breast cancer patients. SABCS

Now out in Journal of Clinical Oncology the results of our global collaboration🌎 led by Matteo Lambertini, MD PhD showing different clinical behavior of breast cancer in young BRCA1 and BRCA2 carriers, and the impact of timing of genetic testing on prognosis - a thread👇🏻🧵 OncoAlert ascopubs.org/doi/10.1200/JC…

Hot of the press IJROBP - The Red Journal: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial Full text here: doi.org/10.1016/j.ijro…

Join us for the Practical guide to combine novel systemic therapies and radiation therapy pre-meeting course! 🗓 2 May 2025 | 📍 Straus 1-2 👉 Watch & register: bit.ly/40qzPYA #ESTRO25 #radonc #OncoAlert OncoAlert

At #ECHNO 2025: where we talk heads, necks, and everything in between. Science, networking, and maybe a little fun—strictly evidence-based, of course! #HeadAndNeckCancer Pierluigi Bonomo

Proud of CarlottaB - Honoured to present on behalf of the #BRCABCYcollaboration led by Matteo Lambertini, MD PhD Università di Firenze Azienda Ospedaliero-Universitaria Careggi #ESTRO25 to optimise loco-regional therapy in young #BRCA carriers with #BreastCancer OncoAlert ESTRO Università di Genova Ospedale San Martino Genova Eva Blondeaux

Amazing Pierluigi Bonomo at the meet the expert session on head and neck guidelines in delineation #ESTRO25 ROs essential in the preoperative decision making process #radonc #OncoAlert OncoAlert

My #RadOnc ⚛️ physics team is the BEST! 👏🏻Big thanks to Prof. Livia Marrazzo for today’s inspiring overview on Automated treatment planning for breast cancer. Truly beaming with gratitude & hope! 🌟💪 #Innovation #CancerCare #ESTRO2025

Heart matters!🫀❤️ #Cardioprotection in #anthracycline treated #BreastCancer patients: final analysis from the 2x2 randomized, placebo-controlled, double-blind SAFE trial Article link: authors.elsevier.com/sd/article/S20… Università di Firenze Azienda Ospedaliero-Universitaria Careggi ESMO Open OncoAlert #OncoAlert